Trade Ideas
Actionable trade ideas with entry/stop/target and risk framing.
Investors Back U.S. Gold - Time to Upgrade to 'Buy' as Lenders May Follow
Strong liquidity, recent financing and derisked U.S. projects make USAU a tactically attractive long; entry band, stop and two targets provided.
U.S. Gold Corp (USAU) is a development-stage gold company with permitted projects in Wyoming, Nevada and Idaho. Recent financings, a materially strong...
IAC: Deep Discount to Book and Improving Ops - A Tactical Long
Two catalysts — asset-value realization and operational stabilization — could force a re-rate from a depressed base
IAC is trading well below its balance-sheet equity while underlying operating metrics have stabilized across 2025. With implied market cap roughly $3....
Chevron in a Tight Spot - A Tactical Short on Political Risk, Not Fundamentals
Positioning for a Venezuela-driven headline shock; tradeable entry, stops and targets for a swing trade
Chevron (CVX) is a high-quality, cash-generative integrated oil major with a thick balance sheet and a 4.4% cash yield at current prices. That strengt...
TSMC: AI Demand + Dividend Growth, But the Market Still Prices a Risk Premium
Buy the structural leader on a multi-month horizon — entry zone, stop, and two targets laid out
TSMC sits squarely at the center of the AI-driven semiconductor recovery: dominant process technology, a blue-chip customer base, accelerating dividen...
Cenovus (CVE): Position for a 2026 Reset — defined entry, stop and targets
MEG integration, fresh financing and a renewed buyback make the next 6-12 months tradeable; size risk and be disciplined
Cenovus has reshaped the playbook heading into 2026 - a sizable oil sands acquisition closed in November 2025, a $2.6 billion senior-note financing, a...
Okta: The Identity Bedrock For Agentic AI - Upgrade to Long (Actionable Trade)
Identity becomes the chassis for agentic AI - Okta is quietly positioned to capture the trust, orchestration and enforcement layer enterprises will pay for.
Okta's core IAM franchise is showing revenue acceleration, recurring profitability and strong operating cash flow. Combine that with the emerging need...
Michelin: Buybacks + Dividend Growth Make 16.75 an Attractive Long-Term Entry
Structural product wins and ongoing share repurchases support a constructive long-term trade; entry, stop and layered targets provided.
Michelin's combination of shareholder-friendly buybacks, steady dividend growth and targeted bolt-on M&A into Polymer Composite Solutions makes the eq...
Root as Carvana's De Facto Insurance Arm - A High-Conviction Swing Trade
Root's telematics + improving underwriting could make it the default auto-insurance partner for used-car platforms; trade plan and risks inside.
Root is showing consistent cash generation, narrower underwriting volatility, and a materially reduced debt load. If management leans into distributio...
VTEX: Deep Discount to Platform Potential — Buy for FCF Growth, Trim Position Size
Software commerce exposure at ~3.63 - an option-like long on free-cash-flow upside amid macro noise
VTEX is a SaaS commerce platform with concentrated revenue in Brazil and Latin America. The stock trades near multi-month lows (~$3.63 as of 01/03/202...
Stevanato: Buy Confirmed - Structural Demand Intact, Pullback Offers Tactical Entry
Prefilled-syringes growth and steady cash returns make STVN a tactical buy around $20.5 with defined stops and upside to the mid-$20s and beyond.
Stevanato Group supplies critical drug containment and delivery products to pharma and biotech. The stock has pulled back ~25-30% from summer highs wh...
Buying the AI Narrative — Raising My AMD Conviction Into CES 01/2026
Fundamentals look healthy; this is a tactical long into a CES-driven catalyst with clear proof points and a defined risk plan.
I am increasing my long exposure to Advanced Micro Devices (AMD) ahead of CES 2026. Q3 FY2025 showed a meaningful revenue rebound (9.246B) and expandi...
Healthcare Realty (HR) - Buy a Durable Healthcare REIT While the Market Misprices Risk
Strong cash flow, active JV asset sales, and an attractive yield on a lower share base make HR a high-conviction buy at current levels
Healthcare Realty (HR) is a defensible, outpatient-focused REIT trading ~17 and offering a 5.5%-6% yield on the new payout run-rate. Recent quarter re...